Infosim takes over SKOOR
The software company Infosim GmbH & Co. KG, based in Würzburg, a leading international provider of automated service fulfilment and service assurance solutions for telcos, ISPs, managed service providers and enterprises, has...
Sale of T3 Pharmaceuticals AG to Boehringer Ingelheim
T3 Pharmaceuticals AG, a biotechnology company with its headquarter in Allschwil, Switzerland has been acquired by Boehringer Ingelheim, a leading family-owned, research-driven biopharmaceutical company based in Ingelheim, Germany...
VISCHER advises Bregal on the acquisition of Netrics Group
Funds advised by Bregal Unternehmerkapital acquire Netrics Group, one of the largest cloud and modern workplace providers in Switzerland, from Waterland Private Equity. The transaction is accompanied by a reinvestment of the...
Nouscom Raises EUR 67.5m in Oversubscribed Series C Financing Round
Nouscom AG, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, today announced the completion of its oversubscribed Series C equity financing raising EUR 67.5m (USD 72m) from a syndicate of re-nowned international healthcare investors.
LASCCO and Abionic enter license agreement with Fapon
LASCCO SA, a biomedical-technology company, and Abionic SA, a nanotechnology company, both based at the Biopôle of Lausanne, Switzerland, entered into a licensing agreement with Fapon Biotech, a global leading life sciences company, based in Dongguan, China, for the use of the pancreatic stone protein (PSP) biomarker for sepsis diagnosis in China.
Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients
Memo Therapeutics AG, a late-stage biotech company developing best-in-class therapeutic antibodies closed a CHF25 million series C financing round led by Pureos Bioventures.
VISCHER advises Swiss Post on its acquisition of a stake in STERIPARC SA.
Yverdon-les-Bains-based STERIPARC SA is a joint venture for the outsourced processing of medical devices in Western Switzerland. Thanks to this partnership, Swiss Post is expanding its existing logistics services in the healthcare...
LimmaTech Biologics Raises USD 37m Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections
LimmaTech Biologics AG announced the closing of a USD 37m (CHF 33m) Series A financing round co-led by Adjuvant Capital, AXA IM Alts, and the Novo Holdings REPAIR Impact Fund.
Afinum invests in Hofstetter PCB AG
Afinum invests in Hofstetter PCB AG (Hofstetter), the leading European provider of printed circuit boards plating and special final finishing services.
Longevity startup Epiterna raises EUR 10million from Prima Materia
Epiterna SA ("Epiterna") has raised EUR 10 million from Prima Materia, an investment firm founded by Spotify founder Daniel Ek and investor and early Spotify backer Shakil Khan.